nifedipine has been researched along with Vascular Diseases in 19 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nifedipine antagonises influx of calcium through cell membrane slow channels, and sustained release formulations of the calcium channel blocker have been shown to be effective in the treatment of mild to moderate hypertension and both stable and variant angina pectoris." | 8.78 | Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders. ( Brogden, RN; Murdoch, D, 1991) |
| "To explore the effects and related mechanism of nifedipine on vascular inflammation induced by cuff placement." | 7.76 | [Nifedipine attenuates vascular inflammation via inhibin NF-κB activity]. ( Gao, XY; Liu, SK; Lu, FQ; Yu, Q; Zhang, ST; Zhou, SM, 2010) |
| " We, along with others, have recently found that nifedipine, one of the most widely used DHPs, inhibits apoptotic cell death of endothelial cells (ECs) as well as vascular inflammation and subsequently improves endothelial function in patients with cardiovascular risk factors, including hypertension and/or diabetes, thus slowing the development and progression of atherosclerosis in these patients." | 4.84 | Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine. ( Matsui, T; Nakamura, K; Yamagishi, S, 2008) |
| "Nifedipine antagonises influx of calcium through cell membrane slow channels, and sustained release formulations of the calcium channel blocker have been shown to be effective in the treatment of mild to moderate hypertension and both stable and variant angina pectoris." | 4.78 | Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders. ( Brogden, RN; Murdoch, D, 1991) |
| "To explore the effects and related mechanism of nifedipine on vascular inflammation induced by cuff placement." | 3.76 | [Nifedipine attenuates vascular inflammation via inhibin NF-κB activity]. ( Gao, XY; Liu, SK; Lu, FQ; Yu, Q; Zhang, ST; Zhou, SM, 2010) |
| "Breast pain is a common complaint among lactating women." | 1.33 | Vasospasm of the nipple presenting as painful lactation. ( McKenna, DS; Page, SM, 2006) |
| "Treatment with nifedipine did not significantly change any of the pulmonary function values, except for the carbon monoxide diffusing capacity (DLCO)." | 1.28 | Diffusing capacity of the lung and nifedipine in systemic sclerosis. ( Georgiakodis, F; Kyriakidis, M; Papazoglou, S; Sfikakis, P; Sfikakis, PP; Toutouzas, P; Vergos, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (63.16) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, XY | 1 |
| Yu, Q | 1 |
| Liu, SK | 1 |
| Lu, FQ | 1 |
| Zhou, SM | 1 |
| Zhang, ST | 1 |
| Garrison, CP | 1 |
| Yamasaki, K | 1 |
| Aoki, M | 1 |
| Makino, H | 1 |
| Hashiya, N | 1 |
| Shimizu, H | 1 |
| Ohishi, M | 1 |
| Ogihara, T | 1 |
| Morishita, R | 1 |
| Page, SM | 1 |
| McKenna, DS | 1 |
| Yamagishi, S | 1 |
| Nakamura, K | 1 |
| Matsui, T | 1 |
| Luckhaus, G | 2 |
| Garthoff, B | 2 |
| Kazda, S | 2 |
| Hodara, M | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| Cornacchia, D | 1 |
| Finzi, CM | 1 |
| Marchi, G | 1 |
| Murdoch, D | 1 |
| Brogden, RN | 1 |
| Sfikakis, PP | 1 |
| Kyriakidis, M | 1 |
| Vergos, C | 1 |
| Papazoglou, S | 1 |
| Georgiakodis, F | 1 |
| Toutouzas, P | 1 |
| Sfikakis, P | 1 |
| Becker, GJ | 1 |
| Katzen, BT | 1 |
| Dake, MD | 1 |
| Belcaro, G | 1 |
| Nicholaides, AN | 1 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Ahn, YS | 1 |
| Jy, W | 1 |
| Harrington, WJ | 1 |
| Shanbaky, N | 1 |
| Fernandez, LF | 1 |
| Haynes, DH | 1 |
| Barst, RJ | 1 |
| Stalcup, SA | 1 |
| Steeg, CN | 1 |
| Hall, JC | 1 |
| Frosolono, MF | 1 |
| Cato, AE | 1 |
| Mellins, RB | 1 |
| Teba, L | 1 |
| Smailer, S | 1 |
| Taylor, HC | 1 |
| Nash, G | 1 |
| Feller, W | 1 |
6 reviews available for nifedipine and Vascular Diseases
| Article | Year |
|---|---|
Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine.
Topics: Antioxidants; Apoptosis; Atherosclerosis; Calcium Channels; Cardiovascular Diseases; Cytokines; Diab | 2008 |
[Calcium antagonists in cardiology].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Human | 1978 |
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Topics: Coronary Disease; Delayed-Action Preparations; Drug Combinations; Drug Design; Humans; Hypertension; | 1991 |
Noncoronary angioplasty.
Topics: Angioplasty, Balloon; Aspirin; Constriction, Pathologic; Heparin; Humans; Nifedipine; Nitroglycerin; | 1989 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
1 trial available for nifedipine and Vascular Diseases
| Article | Year |
|---|---|
Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor.
Topics: Adult; Calcium Channel Blockers; Endothelium, Vascular; Hepatocyte Growth Factor; Humans; Male; Nife | 2004 |
12 other studies available for nifedipine and Vascular Diseases
| Article | Year |
|---|---|
[Nifedipine attenuates vascular inflammation via inhibin NF-κB activity].
Topics: Animals; Blood Vessels; Chemokine CCL2; Inflammation; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Ni | 2010 |
Nipple vasospasms, Raynaud's syndrome, and nifedipine.
Topics: Adult; Female; Humans; Muscle, Smooth, Vascular; Nifedipine; Nipples; Raynaud Disease; Spasm; Vascul | 2002 |
Vasospasm of the nipple presenting as painful lactation.
Topics: Adult; Breast Feeding; Female; Humans; Lactation; Nifedipine; Nipples; Pain; Raynaud Disease; Vascul | 2006 |
Prevention of hypertensive vasculopathy by nifedipine in salt-loaded Dahl rats.
Topics: Animals; Blood Pressure; Body Weight; Female; Hematocrit; Hypertension; Nifedipine; Pyridines; Rats; | 1982 |
[Treatment of stage II arteriopathy of the lower limbs with coronary involvement (author's transl)].
Topics: Arterial Occlusive Diseases; Arteries; Coronary Disease; Diltiazem; Humans; Leg; Nifedipine; Physica | 1981 |
[Preliminary evaluation of the use of nifedipine in peripheral circulatory disorders on a functional basis].
Topics: Adult; Aged; Blood Circulation; Cold Temperature; Drug Evaluation; Female; Humans; Male; Middle Aged | 1978 |
Diffusing capacity of the lung and nifedipine in systemic sclerosis.
Topics: Adult; Carbon Monoxide; Drug Administration Schedule; Female; Hemodynamics; Humans; Lung Diseases; M | 1990 |
Microvascular evaluation of the effects of nifedipine in vascular patients by laser-Doppler flowmetry.
Topics: Diabetic Angiopathies; Female; Foot; Humans; Lasers; Male; Microcirculation; Middle Aged; Nifedipine | 1989 |
Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine.
Topics: Arteriosclerosis; Blood Platelets; Calcium; Homeostasis; Humans; Nifedipine; Thrombosis; Vascular Di | 1987 |
Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child.
Topics: 6-Ketoprostaglandin F1 alpha; Aging; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Diltiazem; | 1985 |
Effect of nifedipine on TRH stimulation of TSH and PRL release by the pituitary gland.
Topics: Adult; Aged; Female; Heart Diseases; Humans; Hypothalamo-Hypophyseal System; Joint Diseases; Male; M | 1985 |
Healing of malignant hypertensive arteriopathy in Dahl rats by nifedipine.
Topics: Animals; Blood Pressure; Female; Hypertension; Mesenteric Arteries; Nifedipine; Rats; Sodium Chlorid | 1985 |